The effect of HIV and HPV coinfection on cervical COX-2 expression and systemic prostaglandin E 2 levels

Cancer Prevention Research

Volumn 5, Issue 1, 2012, Pages 34-40

  Fitzgerald, Daniel W ^a   Bezak, Karl ^a   Ocheretina, Oksana ^a   Riviere, Cynthia ^c   Wright, Thomas C ^b   Milne, Ginger L ^d   Zhou, Xi Kathy ^a   Du, Baoheng ^a   Subbaramaiah, Kotha ^a   Byrt, Erin ^a   Goodwin, Matthew L ^a   Rafii, Arash ^e   Dannenberg, Andrew J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b College of Physicians and Surgeons ^*  (United States)

^c Department of Adolescent Medicine   (Haïti)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; CYCLOOXYGENASE 2; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MIXED INFECTION; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PROTEIN EXPRESSION; SQUAMOUS EPITHELIUM; URINE CYTOLOGY; URINE LEVEL; UTERINE CERVIX CANCER; WART VIRUS;

ADULT; AIDS SERODIAGNOSIS; CERVIX UTERI; COMORBIDITY; CREATININE; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HAITI; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INFLAMMATION; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RNA, MESSENGER;

EID: 84862907776     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0496     Document Type: Article

References (49)

1. Dubé MP, Sattler FR. Inflammation and complications of HIV disease. J Infect Dis 2010;201:1783-5.
2. Giorgi JV, Liu Z, Hultin LE, Cumberland WG, Hennessey K, Detels R. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1993;6:904-12. (Pubitemid 23207458)
3. Tien PC, Choi AI, Zolopa AR, Benson C, Tracy R, Scherzer R, et al. Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort. J Acquir Immune Defic Syndr 2010;55:316-22.
4. Rigas B, Goldman IS, Levine L. Altered eicosanoid levels in human colon cancer. J Lab Clin Med 1993;122:518-23. (Pubitemid 23352474)
5. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998;93:705-16. (Pubitemid 28257578)
6. Ben-Av P, Crofford LJ, Wilder RL, Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett 1995;372:83-7.
7. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995;83:493-501.
8. 2increases growth and motility of colorectal carcinoma cells. J Biol Chem 2001;276:18075-81.
9. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A 1997;94:3336-40. (Pubitemid 27157312)
10. Sharma S, Yang SC, Zhu L, Reckamp K, Gardner B, Baratelli F, et al. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+CD25+T regulatory cell activities in lung cancer. Cancer Res 2005;65:5211-20. (Pubitemid 40827331)
11. Subbaramaiah K, Telang N, Ramonetti JT, Araki R, DeVito B, Weksler BB, et al. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 1996;56:4424-9. (Pubitemid 26330450)
12. Dannenberg AJ, Subbaramaiah K. Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Cancer Cell 2003;4:431-6. (Pubitemid 38050040)
13. Ryu H-S, Chang K-H, Yang H-W, Kim M-S, Kwon H-C, Oh K-S. High cyclooxygenase-2 expression in stage 1B cervical cancer with lymph node metastasis or parametrial invasion. Gynecol Oncol 2000;76:320-5. (Pubitemid 30131501)
14. Kulkarni S, Rader JS, Zhang F, Liapis H, Koki AT, Masferrer JL, et al. Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin Cancer Res 2001;7:429-34. (Pubitemid 32183049)
15. Sales KJ, Katz AA, Davis M, Hinz S, Soeters RP, Hofmeyr MD, et al. Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. J Clin Endocrinol Metab 2001;86:2243-9. (Pubitemid 32472947)
16. Subbaramaiah K, Dannenberg AJ. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins. Evidence of a corepressor/coactivator exchange. Cancer Res 2007;67:3976-85. (Pubitemid 46762188)
17. Gaffney DK, Holden J, Zempolich K, Murphy KJ, Dicker AP, Dodson M. Elevated COX-2 expression in cervical carcinoma: reduced cause-specific survival and pelvic control. Am J Clin Oncol 2001;24:443-6. (Pubitemid 32959099)
18. Ferrandina G, Lauriola L, Distefano MG, Zannoni GF, Gessi M, Legge F, et al. Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients. J Clin Oncol 2002;20:973-81. (Pubitemid 34141840)
19. Kim YB, Kim GE, Cho NH, Pyo HR, Shim SJ, Chang SK, et al. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy. Cancer 2002;95:531-9.
20. Longo N, Zabay JM, Sempere JM, Navarro J, Fernández-Cruz E. Altered production of PGE2, IL-1 beta and TNF-alpha by peripheral blood monocytes from HIV-positive individuals at early stages of HIV infection. J Acquir Immune Defic Syndr 1993;6:1017-23. (Pubitemid 23239773)
21. Ramis I, Roselló-Catafau J, Gómez G, Zabay JM, Fernández Cruz E, Gelpí E. Cyclooxygenase and lipoxygenase arachidonic acid metabolism by monocytes from human immune deficiency virus-infected drug users. J Chromatogr 1991;557:507-13.
22. Barreto-de-Souza V, Pacheco GJ, Silva AR, Castro-Faria-Neto HC, Bozza PT, Saraiva EM, et al. Increased Leishmania replication in HIV-1-infected macrophages is mediated by tat protein through cyclooxygenase-2 expression and prostaglandin E2 synthesis. J Infect Dis 2006;194:846-54. (Pubitemid 44344134)
23. Liu QN, Reddy S, Sayre JW, Pop V, Graves MC, Fiala M. Essential role of HIV type 1-infected and cyclooxygenase 2-activated macrophages and T cells in HIV type 1 myocarditis. AIDS Res Hum Retroviruses 2001;17:1423-33. (Pubitemid 33042810)
24. Alvarez S, Serramía MJ, Fresno M, Muñoz-Fernández MA. HIV-1 envelope glycoprotein 120 induces cyclooxygenase-2 expression in astrocytoma cells through a nuclear factor-kappaB-dependent mechanism. Neuromolecular Med 2007;9:179-93. (Pubitemid 47065545)
25. Pereira CF, Boven LA, Middel J, Verhoef J, Nottet HS. Induction of cyclooxygenase-2 expression during HIV-1-infected monocyte-derived macrophage and human brain microvascular endothelial cell interactions. J Leukoc Biol 2000;68:423-8.
26. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus associated cancers in patients with HIV and AIDS. J Natl Cancer Inst 2000;92:1500-10.
27. Fink VI, Shepherd BE, Cesar C, Krolewiecki A, Wehbe F, Cortés CP, et al. Cancer in HIV-infected Persons from the Caribbean, Central and South America. J Acquir Immune Defic Syndr 2010;56:467-73.
28. Fitzgerald DW, Marotte C, Verdier RI, Johnson WD Jr, Pape JW. Comprehension during informed consent in a less-developed country. Lancet 2002;360:1301-2. (Pubitemid 35284623)
29. Severe P, Jean Juste MA, Ambroise A, Eliacin L, Marchand C, Apollon S, et al. Early Versus Standard Antiretroviral Therapy for HIV Infected Adults in Haiti. N Engl J Med 2010;363:257-65.
30. Solomon D, Davey D, Kurman R, Moriarity A, O'Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9. (Pubitemid 34437346)
31. Ferretti A, Flanagan VP, Roman JM. Quantitative analysis of 11 alpha-hydroxy-9,15-dioxo-2,3,4,5,20-pentanor-19-carboxyprostanoic acid, the major urinary metabolite of E prostaglandins in man. Ann Biochem 1983;128:351-8. (Pubitemid 13132641)
32. Murphey LJ, Williams MK, Sanchez SC, Byrne LM, Csiki I, Oates JA, et al. Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase- specific PGE2 synthesis in healthy humans and those with lung cancer. Ann Biochem 2004;334:266-75. (Pubitemid 39370961)
33. Hamberg M, Samuelsson B. On the metabolism of prostaglandins E 1 and E 2 in man. J Biol Chem 1971;246:6713-21.
34. Hamberg M, Samuelsson B. The structure of the major urinary metabolite of prostaglandin E2 in man. J Am Chem Soc 1969;91:2177-8.
35. Oates JA, FitzGerald GA, Branch RA, Jackson EK, Knapp HR, Roberts LJ II. Clinical implications of prostaglandin and thromboxane A2 formation. N Engl J Med 1988;319:761-7.
36. Schweer H, Meese CO, Seyberth HW. Determination of 11 alpha-hydroxy-9,15-dioxo-2,3,4,5,20-pentanor-19-carboxyprostanoic acid and 9 alpha,11 alpha-dihydroxy-15-oxo-2,3,4,5,20-pentanor-19-carboxyprostanoic acid by gas chromatography/negative ion chemical ionization triple-stage quadrupole mass spectrometry. Ann Biochem 1990;189:54-8. (Pubitemid 20262975)
37. Piper PJ, Vane JR, Wyllie JH. Inactivation of prostaglandins by the lungs. Nature 1970;225:600-4.
38. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr 1974;19:716-23.
39. Duffield-Lillico AJ, Boyle JO, Zhou XK, Ghosh A, Butala GS, Subbaramaiah K, et al. Levels of prostaglandin E metabolite and leukotriene E4 are increased in the urine of smokers. Evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway. Cancer Prev Res 2009;2:322-9.
40. Csiki I, Morrow JD, Sandler A, Shyr Y, Oates J, Williams MK, et al. Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxel. Clin Cancer Res 2005;11:6634-40. (Pubitemid 41339004)
41. Rahmouni S, Aandahl EM, Nayjib B, Zeddou M, Giannini S, Verlaet M, et al. Cyclo-oxygenase type 2-dependent prostaglandin E2 secretion is involved in retrovirus-induced T-cell dysfunction in mice. Biochem J 2004;384:469-76. (Pubitemid 40018960)
42. Cai Q, Gao YT, Chow WH, Shu XO, Yang G, Ji BT, et al. Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk. J Clin Oncol 2006;24:5010-6. (Pubitemid 46631404)
43. Kekatpure VD, Boyle JO, Zhou XK, Duffield-Lillico AJ, Gross ND, Lee NY, et al. Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients. Cancer Prev Res 2009;2;957-65.
44. Blanco A, Alvarez S, Fresno M, Muñoz-Fernández MA. Extracellular HIV-Tat induces cyclooxygenase-2 in glial cells through activation of nuclear factor of activated T cells. J Immunol 2008;180:530-40.
45. Neuhaus J, Jacobs DR Jr, Baker JV, Calmy A, Duprez D, La Rosa A, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 2010;201:1788-95.
46. Cozzi-Lepri A, French MA, Baxter J, Okhuysen P, Plana M, Neuhaus J, et al. Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial. AIDS 2011;25:1207-17.
47. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006;12:1365-71. (Pubitemid 44924494)
48. Steenport M, Khan KMF, Du B, Barnhard SE, Dannenberg AJ, Falcone DJ. Matrix metalloproteinase (MMP)-1 and MMP-3 induce macrophage MMP-9: evidence for the role of TNF-α and cyclooxygenase-2. J Immunol 2009;183:8119-27.
49. + smokers with early emphysema. J Leukoc Biol 2009;86:913-22.